Vacsera Biological Products & Vaccines Holding Company Company Profile

21:31 EDT 16th September 2014 | BioPortfolio

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,products
and services as well as our affiliated companies.

Vacsera is the leading company in the field of biological products &vaccines
manufacturing in Egypt and the Middle East.

We are focused on pursuing strategic investment opportunities in a number
of sectors within the pharmaceutical and biopharmaceutical industries.

These include research and development, manufacturing, distribution, and intellectual property acquisitions.

Location

51 Wizaret El-Zeraa - Agouza
Giza
22311
Egypt

Contact

Phone: (202) 76 111 11
Fax: (202) 33 698 72
Email: ceo@vacsera.com


News Articles [1716 Associated News Articles listed on BioPortfolio]

Admedus Buys More Of Vaccines Unit On Herpes Trial Success

Australia's Admedus has bought another 15% of its Admedus Vaccines subsidiary to give it a 66.3% holding.

Using Spray Drying For Flu Vaccines: What Challenges Do We Need To Overcome?

When discussing the challenges of manufacturing flu vaccines, the conversation often shifts toward how manufacturers can meet the global demand each year. Currently there are some very innovative tech...

FDA's Purple Book to Catalog Biologics, Biosimilars

The “Purple Book” lists biological products, including any biosimilar and interchangeable biological products licensed by FDA

GSK Swaps Cancer For Vaccines As It Sheds Legacy Products, Not R&D

Complex transaction with Novartis leaves the British drug maker with a better balanced portfolio centered on vaccines, consumer health, respiratory and HIV medicines.

Pfizer to acquire Baxter's marketed vaccines

Pfizer Inc. (NYSE:PFE) will acquire the marketed vaccine portfolio of Baxter International Inc. (NYSE:BAX) for $635 million in cash. Baxter's marketed vaccines are NeisVac-C, a group C meningococcal p...

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu,...

First biosimilar hits the market

Making a generic version of a single molecule drug is fairly straightforward.  Making a replica of a biologic treatment, however, is not.  Nevertheless, Congress signed into law the Biologics Pric...

Merck, Novartis, Medimmune, And Sanofi Go Head to Head

The big guns take to the stage at the World Vaccines Congress USA to talk about everything from pre-clinical all the way through to commercialisation and distribution of products. It may be a long wat...

PubMed Articles [2286 Associated PubMed Articles listed on BioPortfolio]

Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy.

Monoclonal antibodies, modern vaccines and gene therapy have become a major field in modern biotechnology, especially in the area of human health and fascinating developments achieved in the past deca...

Isolation of Bacillus cytotoxicus from various commercial potato products.

Bacillus (B.) cytotoxicus is a newly described thermotolerant member of the Bacillus cereus group. This potential foodborne pathogen had so far only been isolated from vegetable products, including ma...

Estimation and approximation approaches for biosimilar index based on reproducibility probability.

Abstract In recent years, quantitative evaluation for biosimilarity has been taken seriously due to the development of biosimilar products. The concept for assessment of biological products is very di...

Recent progress and concerns regarding the Japanese immunization program: Addressing the "vaccine gap"

Recent progress in the Japanese immunization program has partially closed the "vaccine gap," i.e., the deficiencies in that program relative to immunization programs in other developed countries. Duri...

Effect of number and washing solutions on functional properties of surimi-like material from duck meat.

Duck meat is less utilized than other meats in processed products because of limitations of its functional properties, including lower water holding capacity, emulsion stability, and higher cooking lo...

Clinical Trials [1682 Associated Clinical Trials listed on BioPortfolio]

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Prevention of Radiation Pneumonitis After Three-Dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-Small-Cell Lung Cancer

The purpose of this study is to evaluate the interest of breath holding for the prevention of radiation pneumonitis following conformal radiation therapy. Eligible patients will be random...

The Holding Study: Feeding Analgesia in Preterm Infants

The purpose of this study is to compare the effects of mothers' skin-to-skin holding during feeding via a soother trainer with the effects of pacifier sucking on preterm infant biobehaviou...

A Study to Test the Safety of Three Experimental HIV Vaccines

The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the ...

Companies [1452 Associated Companies listed on BioPortfolio]

Vacsera Biological Products & Vaccines Holding Company

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,productsand services as well as our affiliated companies.Va...

Biological E Limited

Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...

Embrex Incorporated

Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity andprofitability of the global poultry industry. Embrex has developed and commerci...

ASCIInc

ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system includi...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...

More Information about "Vacsera Biological Products & Vaccines Holding Company" on BioPortfolio

We have published hundreds of Vacsera Biological Products & Vaccines Holding Company news stories on BioPortfolio along with dozens of Vacsera Biological Products & Vaccines Holding Company Clinical Trials and PubMed Articles about Vacsera Biological Products & Vaccines Holding Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vacsera Biological Products & Vaccines Holding Company Companies in our database. You can also find out about relevant Vacsera Biological Products & Vaccines Holding Company Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record